149 related articles for article (PubMed ID: 11943186)
1. Site-directed mutagenesis of the type II TGF-beta receptor indicates a ligand-binding site distinct from that of the type II activin receptor.
Guimond A; Sulea T; Pen A; Ear P; O'Connor-McCourt MD
FEBS Lett; 2002 Mar; 515(1-3):13-9. PubMed ID: 11943186
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
Liu X; Nagarajan RP; Vale W; Chen Y
FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
[TBL] [Abstract][Full Text] [Related]
3. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.
Rotzer D; Roth M; Lutz M; Lindemann D; Sebald W; Knaus P
EMBO J; 2001 Feb; 20(3):480-90. PubMed ID: 11157754
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
5. Mapping of putative binding sites on the ectodomain of the type II TGF-beta receptor by scanning-deletion mutagenesis and knowledge-based modeling.
Guimond A; Sulea T; Pepin MC; O'Connor-McCourt MD
FEBS Lett; 1999 Jul; 456(1):79-84. PubMed ID: 10452534
[TBL] [Abstract][Full Text] [Related]
6. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
7. TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor.
Kim YW; Park J; Lee HJ; Lee SY; Kim SJ
Biochem J; 2012 Aug; 445(3):403-11. PubMed ID: 22571197
[TBL] [Abstract][Full Text] [Related]
8. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
[TBL] [Abstract][Full Text] [Related]
9. Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.
Rechtman MM; Nakaryakov A; Shapira KE; Ehrlich M; Henis YI
J Biol Chem; 2009 Mar; 284(12):7843-52. PubMed ID: 19147499
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding.
De Crescenzo G; Pham PL; Durocher Y; O'Connor-McCourt MD
J Mol Biol; 2003 May; 328(5):1173-83. PubMed ID: 12729750
[TBL] [Abstract][Full Text] [Related]
11. Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.
Fernandez T; Amoroso S; Sharpe S; Jones GM; Bliskovski V; Kovalchuk A; Wakefield LM; Kim SJ; Potter M; Letterio JJ
J Exp Med; 2002 May; 195(10):1247-55. PubMed ID: 12021305
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.
Wells RG; Gilboa L; Sun Y; Liu X; Henis YI; Lodish HF
J Biol Chem; 1999 Feb; 274(9):5716-22. PubMed ID: 10026191
[TBL] [Abstract][Full Text] [Related]
13. Identification of a functional binding site for activin on the type I receptor ALK4.
Harrison CA; Gray PC; Koerber SC; Fischer W; Vale W
J Biol Chem; 2003 Jun; 278(23):21129-35. PubMed ID: 12665502
[TBL] [Abstract][Full Text] [Related]
14. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY
J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829
[TBL] [Abstract][Full Text] [Related]
15. Identification of a functional site on the type I TGF-beta receptor by mutational analysis of its ectodomain.
Guimond A; Sulea T; Zwaagstra JC; Ekiel I; O'Connor-McCourt MD
FEBS Lett; 2002 Feb; 513(2-3):147-52. PubMed ID: 11904140
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts.
Chang W; Parra M; Ji C; Liu Y; Eickelberg O; McCarthy TL; Centrella M
Gene; 2002 Oct; 299(1-2):65-77. PubMed ID: 12459253
[TBL] [Abstract][Full Text] [Related]
17. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling.
Quan T; He T; Kang S; Voorhees JJ; Fisher GJ
Am J Pathol; 2004 Sep; 165(3):741-51. PubMed ID: 15331399
[TBL] [Abstract][Full Text] [Related]
18. Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.
Radaev S; Zou Z; Huang T; Lafer EM; Hinck AP; Sun PD
J Biol Chem; 2010 May; 285(19):14806-14. PubMed ID: 20207738
[TBL] [Abstract][Full Text] [Related]
19. Albumin endocytosis in endothelial cells induces TGF-beta receptor II signaling.
Siddiqui SS; Siddiqui ZK; Malik AB
Am J Physiol Lung Cell Mol Physiol; 2004 May; 286(5):L1016-26. PubMed ID: 14729511
[TBL] [Abstract][Full Text] [Related]
20. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]